As of 2026-03-31, 昆明梓橦宫全新生物制药's data on the DeepSeek platform in the 医药制造 category shows: The overall mention rate is 0.00%, below the industry average by 23.6 percentage points, with significant room for improvement. The first mention rate is only 0.00%, it is recommended to enhance first-position exposure in AI model responses. Negative mention rate (0.00%) has exceeded positive (0.00%), it is recommended to immediately initiate reputation repair. Among 6 competitors in the same category, 昆明梓橦宫全新生物制药's overall mention rate surpasses 0 brands. AIGeo recommends combining the above data to formulate targeted brand monitoring strategies to further enhance brand visibility and reputation in the AI search ecosystem.
昆明梓橦宫全新生物制药's Mention Rate is 0.00%, lower than 0.6% of competitors
昆明梓橦宫全新生物制药's First Mention is 0.00%, lower than 0.9% of competitors
昆明梓橦宫全新生物制药's Preferred Rate is 0.00%, lower than 100.0% of competitors
昆明梓橦宫全新生物制药's Positive Rate is 0.00%, lower than 8.9% of competitors
昆明梓橦宫全新生物制药's Negative Rate is 0.00%, higher than 96.3% of competitors
| Competitor | Mention Rate | First Mention | Preferred Rate | Positive Rate | Negative Rate | Actions |
|---|---|---|---|---|---|---|
| 恒恒瑞医药 | 65.22% | 20.29% | 33.33% | 60.87% | 5.8% | View Details |
| 云云南白药 | 20.29% | 0% | 0% | 14.49% | 0% | View Details |
| 北北京同仁堂 | 8.7% | 0% | 0% | 4.35% | 5.8% | View Details |
| 广广东金城金素制药 | 0% | 0% | 0% | 0% | 0% | View Details |
| 斯斯利安药业 | 0% | 0% | 0% | 0% | 0% | View Details |
| 上上海复星医药 | 0% | 0% | 0% | 0% | 0% | View Details |
| 昆昆明梓橦宫全新生物制药 (Current Brand) | 0% | 0% | 0% | 0% | 0% | View Details |
